The lack of a time-related increase in dose-corrected tacrolimus exposure observed with the CYP3A4 * 1 / CYP3A5 * 1 and CYP3A4 * 1B / CYP3A5 * 1 genotypes is associated with tacrolimus -related nephrotoxicity , possibly as a result of higher concentrations of toxic metabolites .